Steward Partners Investment Advisory
PRAX icon

Steward Partners Investment Advisory’s Praxis Precision Medicines PRAX Stock Holding History

Steward Partners Investment Advisory’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.37K Buy
28
+18
+180% +$5.7K ﹤0.01% 3761
2026
Q1 		$3.22K Buy
+10
New +$3.09K ﹤0.01% 3921

Other funds holding PRAX

Jupiter Topco
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Orbis Allan Gray
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Steward Partners Investment Advisory's PRAX Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Praxis Precision Medicines (PRAX) stake by 180% in Q2 2026, buying an estimated $5.7K and bringing the position to 28 shares worth $9.37K. The position accounts for ﹤0.01% of the portfolio, ranked #3761.

Steward Partners Investment Advisory first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Steward Partners Investment Advisory held 28 shares of Praxis Precision Medicines worth $9.37K as of Q2 2026.
  • Steward Partners Investment Advisory bought 18 Praxis Precision Medicines shares in Q2 2026, an estimated $5.7K.
  • Praxis Precision Medicines made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3761 holding.
  • Steward Partners Investment Advisory first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.